Table. Patient and Tumor Characteristics.
| Characteristic | Patients, No. (%) | |||
|---|---|---|---|---|
| Breast cancer (n = 464)a | Pancreatic cancer (n = 807)b | Lung cancer (n = 341)c | Colorectal cancer (n = 702)d | |
| Age, median (range), ye | 61.6 (26.4-90.1) | 70.0 (39.0-93.0) | 65.9 (28.4-88.2) | 66.9 (26.9-92.1) |
| Body mass index, mean (SD)e,f | 27.0 (5.5) | 24.7 (4.6) | 25.3 (4.7) | 26.1 (4.8) |
| Sex | ||||
| Female | 464 (100.0) | 352 (43.6) | 118 (34.6) | 248 (35.3) |
| Male | 0 | 455 (56.4) | 223 (65.4) | 454 (64.7) |
| Eastern Cooperative Oncology Group performance statuse | ||||
| 0 | 258 (55.6) | 313 (38.8) | 109 (32.0) | 325 (46.3) |
| ≥1 | 206 (44.4) | 494 (61.2) | 232 (68.0) | 377 (53.7) |
| Comorbidities, Charlson Comorbidity Indexg,h | ||||
| 0 | 389 (83.8) | 593 (73.5) | 189 (55.4) | 542 (77.2) |
| ≥1 | 75 (16.2) | 214 (26.5) | 152 (44.6) | 160 (22.8) |
| Metastasis at diagnosish | ||||
| No (M0, metachronous) | 259 (55.8) | 207 (25.7) | 92 (27.0) | 175 (24.9) |
| Yes (M1, synchronous) | 150 (32.3) | 494 (61.2) | 247 (72.4) | 487 (69.4) |
| Unknown (MX) | 55 (11.9) | 106 (13.1) | 2 (0.6) | 40 (5.7) |
| Progression | ||||
| Patients without progression | 194 (41.8) | 313 (38.8) | 97 (28.4) | 278 (39.6) |
| Patients with ≥1 progression | 270 (58.2) | 494 (61.2) | 244 (71.6) | 424 (60.4) |
a
Recruited from 2011 to 2016 in 103 centers.
b
Recruited from 2014 to 2018 in 100 centers.
c
Recruited from 2011 to 2013 in 71 centers.
d
Recruited from 2014 to 2017 in 110 centers.
e
At start of treatment.
f
Body mass index is calculated as the weight in kilograms divided by height in meters squared.
g
The Charlson Comorbidity Index is described by Quan et al.31
h
At primary diagnosis.